S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK -7.14%
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stenocare A/S
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Pre-Tax Income
-kr18.8m
CAGR 3-Years
-11%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Pre-Tax Income
kr119.3B
CAGR 3-Years
27%
CAGR 5-Years
20%
CAGR 10-Years
14%
H Lundbeck A/S
CSE:HLUN A
Pre-Tax Income
kr3B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Pre-Tax Income
kr647m
CAGR 3-Years
86%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Pre-Tax Income?
Pre-Tax Income
-18.8m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Pre-Tax Income amounts to -18.8m DKK.

What is Stenocare A/S's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-39%

Over the last year, the Pre-Tax Income growth was -5%. The average annual Pre-Tax Income growth rates for Stenocare A/S have been -11% over the past three years , -39% over the past five years .

Back to Top